Document is current
Any future updates will be listed below
-
Authors
Li, Xuemin
Wang, Luqi
Yang, Mengying
Li, Xianan
Zhao, Ting
Wang, Mingqing
Lu, Siyi
Ji, Yunsong
Zhang, Wei
Jia, Lecheng
Peng, Ran
Wang, Junjie
Wang, Hao https://orcid.org/0000-0002-3504-1983
-
Funding
Funding for this research was provided by:
Cross-joint special fund of Peking University Third Hospital (Y87499-02)
Beijing United Imaging Intelligent Imaging Technology Research Institute Institute-Enterprise Joint R&D Platform Fund (H79462-07)
National Traditional Chinese and Western Medicine Collaborative Flagship Hospital Construction Project (A79462-11)
- License Information
-
More Information
Article History
Received: 17 April 2025
Accepted: 14 July 2025
First Online: 19 August 2025
Declarations
:
: The study protocol was approved by the Institutional Review Board of Peking University Third Hospital (Approval No. (2024) Medical Ethics Review No. 182-01). Informed consent was waived due to the retrospective nature of the study and the use of anonymized data.
: Not applicable.
: The authors declare no competing interests.
: Corresponding author information: Dr. Hao Wang is a Chief Physician, Associate Professor, and PhD Supervisor at the Cancer Center of Peking University Third Hospital. She is recognized as an Outstanding Doctor, a Key Young Academic Member, and a back-up candidate for Academic and Technical Leadership. Her clinical and research interests focus on radiotherapy for gastrointestinal, urological, and lymphatic malignancies.
